Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/67256
Title: The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project
Author: Borràs Andrés, Josep Maria
Barton, Michael
Grau, Cai
Corral, Julieta
Verhoeven, Rob
Lemmens, Valery
Eycken, Liesbet van
Henau, Kris
Primic-Zakelj, Maja
Strojan, Primoz
Trojanowski, Maciej
Dyzmann-Sroka, Agnieszka
Kubiak, Anna
Gasparotto, Chiara
Defourny, Noémie
Malicki, Julian
Dunscombe, Peter
Coffey, Mary
Lievens, Yolande
Keywords: Gestió hospitalària
Gestió de personal
Radioteràpia
Europa
Enquestes
Radiologia
Equipaments sanitaris
Hospital administration
Personnel management
Radiotherapy
Europe
Surveys
Radiology
Health facilities
Issue Date: 1-Jul-2015
Publisher: Elsevier B.V.
Abstract: Background and purpose: The impact of differences in the distribution of major cancer sites and stages at diagnosis among 4 European countries on the optimal utilization proportion (OUP) of patients who should receive external beam radiotherapy was assessed within the framework of the ESTRO-HERO project. Materials and methods: Data from Australian Collaboration for Cancer Outcomes Research and Evaluation (CCORE) were used. Population based stages at diagnosis from the cancer registries of Belgium, Slovenia, the Greater Poland region of Poland, and The Netherlands were used to assess the OUP for each country. A sensitivity analysis was carried out. Results: The overall OUP by country varied from the lowest of 48.3% in Australia to the highest of 53.4% in Poland; among European countries the variation was limited to 3%. Cancer site specific OUPs showed differences according to the variability in stage at diagnosis across countries. The most important impact on the OUP by country was due to changes in relative frequency of tumours rather than stage at diagnosis. Conclusions: This methodology can be adapted using European data, thus facilitating the planning of resources required to cope with the demand for radiotherapy in Europe, taking into account the national variability in cancer incidence.
Note: Versió postprint del document publicat a: http://dx.doi.org/10.1016/j.radonc.2015.04.021
It is part of: Radiotherapy and Oncology, 2015, vol. 116, num. 1, p. 45-50
Related resource: http://dx.doi.org/10.1016/j.radonc.2015.04.021
URI: http://hdl.handle.net/2445/67256
ISSN: 0167-8140
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
652921.pdf425.84 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.